116 related articles for article (PubMed ID: 8204535)
1. Current status and future directions in the perioperative treatment of pancreatic cancer.
Wagener DJ; Punt CJ; Wilke H
Ann Oncol; 1994; 5 Suppl 3():87-90. PubMed ID: 8204535
[TBL] [Abstract][Full Text] [Related]
2. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
3. Multimodality treatment of locally advanced pancreatic cancer.
Wagener DJ; de Mulder PH; Wils JA
Ann Oncol; 1994; 5 Suppl 3():81-6. PubMed ID: 8204534
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy for pancreatic cancer: current status and perspectives.
Oya N
Int J Clin Oncol; 2004 Dec; 9(6):451-7. PubMed ID: 15616875
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.
Labori KJ; Lassen K; Hoem D; Grønbech JE; Søreide JA; Mortensen K; Smaaland R; Sorbye H; Verbeke C; Dueland S
BMC Surg; 2017 Aug; 17(1):94. PubMed ID: 28841916
[TBL] [Abstract][Full Text] [Related]
7. Localized Pancreatic Cancer: Multidisciplinary Management.
Coveler AL; Herman JM; Simeone DM; Chiorean EG
Am Soc Clin Oncol Educ Book; 2016; 35():e217-26. PubMed ID: 27249726
[TBL] [Abstract][Full Text] [Related]
8. Multimodality management of localized pancreatic cancer.
Wayne JD; Wolff RA; Pisters PW; Evans DB
Cancer J; 2001; 7 Suppl 1():S35-46. PubMed ID: 11504284
[TBL] [Abstract][Full Text] [Related]
9. [Current status of adjuvant therapy for pancreatic cancer].
Doi R; Fujimoto K; Wada M; Imamura M
Gan To Kagaku Ryoho; 2002 Mar; 29(3):370-5. PubMed ID: 11915725
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer.
Chadha AS; Khoo A; Aliru ML; Arora HK; Gunther JR; Krishnan S
Semin Radiat Oncol; 2016 Oct; 26(4):320-37. PubMed ID: 27619253
[TBL] [Abstract][Full Text] [Related]
11. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy for pancreatic cancer: current status and future directions.
Xiong HQ; Abbruzzese JL
Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
[TBL] [Abstract][Full Text] [Related]
13. [Selection of methods for diagnosis and treatment of pancreatic cancer].
Ozaki H; Kinoshita T; Kosuge T; Shimada K; Yamamoto J; Inoue K
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2311-8. PubMed ID: 1463336
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
Zhu AX; Clark JW; Willett CG
Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
[TBL] [Abstract][Full Text] [Related]
15. Current and future strategies for combined-modality therapy in pancreatic cancer.
Ko AH; Tempero MA
Curr Oncol Rep; 2002 May; 4(3):202-12. PubMed ID: 11937010
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for pancreatic cancer: to treat or not to treat?
Berlin JD
Oncology (Williston Park); 2007 May; 21(6):712-8; discussion 720, 725-6, 730. PubMed ID: 17564327
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
[TBL] [Abstract][Full Text] [Related]
18. Combined-modality treatment for operable pancreatic adenocarcinoma.
Pisters PW; Wolff RA; Crane CH; Evans DB
Oncology (Williston Park); 2005 Mar; 19(3):393-404, 409; discussion 409-10, 412-6. PubMed ID: 15828554
[TBL] [Abstract][Full Text] [Related]
19. The case for routine use of adjuvant therapy in pancreatic cancer.
Kennedy EP; Yeo CJ
J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
[TBL] [Abstract][Full Text] [Related]
20. [Possibilities and limits of cytostatic chemotherapy in pancreatic carcinoma].
Scheithauer W
Wien Klin Wochenschr; 1994; 106(22):704-8. PubMed ID: 7825320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
